Tag Archives: abbv

Halozyme Stock Hits New High On AbbVie Collaboration

Halozyme Therapeutics (HALO) stock rose to a new high Wednesday after the biotech announced a collaboration with AbbVie (ABBV) that could be worth more than $1.2 billion. AbbVie agreed to pay $23 million upfront and up to $130 million in milestone payments for each of nine targets that it plans to work on using Halozyme’s Enhanze platform, designed to aid the dispersion and absorption of injectable drugs. AbbVie will also pay unspecified tiered

Ambarella Leads 3 Top Stocks Bucking The Sell-Off

The market is bleeding red today, but here are three highly rated stocks holding up during the sell-off: Ambarella (AMBA), AbbVie (ABBV) and Vipshop (VIPS). GoPro (GPRO) chip supplier Ambarella is trading about 1% off its all-time high of 86.75 reached last Wednesday, shortly after finding support at the 50-day line. Tuesday’s volume is tracking above average. The stock is also up about 34% from a consolidation base buy point of 63.30, which

AbbVie Beats Q1 Estimates; Novartis, Alexion Mixed

Thursday morning brought a passel of earnings reports from large-cap drugmakers, which the market greeted with a mostly unenthusiastic response. One of the most anticipated reports came from AbbVie (ABBV), which unveiled its first full quarter with hepatitis C treatment Viekira Pak and addressed questions buzzing around Wall Street about its spending strategy. AbbVie’s Q1 earnings rose 32% over the year-earlier quarter to 94 cents a share, 9 cents